About Us

The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®) was created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH).


Researchers and clinicians are actively developing gene-based therapies to treat ophthalmic genetic diseases that were once considered untreatable. Here is list of Approved eyeGENE® Stage 2 Research Studies as of March 2017.